Back
Silgan Holdings 10K Form
Sell
40
SLGN
Silgan Holdings
Last Price:
$50.69
Seasonality Move:
3.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-08 | 10Q | SLGN/Silgan Holdings Quarterly |
2023-11-02 | 10Q | SLGN/Silgan Holdings Quarterly |
2023-08-03 | 10Q | SLGN/Silgan Holdings Quarterly |
2023-05-03 | 10Q | SLGN/Silgan Holdings Quarterly |
2022-11-03 | 10Q | SLGN/Silgan Holdings Quarterly |
2022-08-04 | 10Q | SLGN/Silgan Holdings Quarterly |
Receive SLGN News And Ratings
See the #1 stock for the next 7 days that we like better than SLGN
SLGN Financial Statistics
Sales & Book Value
Annual Sales: | $5.9B |
---|---|
Cash Flow: | $865M |
Price / Cash Flow: | 11.83 |
Annual Sales: | $18.63 |
Price / Book: | 2.72 |
Profitability
EPS (TTM): | 2.58000 |
---|---|
Net Income (TTM): | $276.4M |
Gross Margin: | $1B |
Return on Equity: | 14.15% |
Return on Assets: | 3.52% |
Silgan Holdings Earnings Forecast
Key Silgan Holdings Financial Ratios
-
The Gross Profit Margin over the past 31 years for SLGN is 17.28%.
-
The Selling, General & Administrative Expenses for SLGN have been equal to 7.47% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 60.20% of Operating Income.
-
The Net Earning history of SLGN is 4.72% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 16 years.
Silgan Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Containers & Packaging |
Sector: | Materials |
Current Symbol: | SLGN |
CUSIP: | 827048 |
Website: | silganholdings.com |
Debt
Debt-to-Equity Ratio: | 2.08 |
---|---|
Current Ratio: | 1.12 |
Quick Ratio: | 0.63 |
Price-to-Earnings
Trailing P/E Ratio: | 19.66 |
---|---|
Forward P/E Ratio: | 11.34 |
SLGN Technical Analysis vs Fundamental Analysis
Sell
40
Silgan Holdings (SLGN)
is a Sell
Is Silgan Holdings a Buy or a Sell?
-
Silgan Holdings stock is rated a SellThe current Silgan Holdings [SLGN] share price is $50.71. The Score for SLGN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.